From “undruggable” to tractable: Therapeutic advances targeting Kristen rat sarcoma viral homolog glycine to cysteine mutation at codon 12 (KRAS G12C)-mutant cancers and emerging resistance mechanisms

Cancer Pathogenesis and Therapy · Elsevier

Аннотация

Publication date: November 2026 Source: Cancer Pathogenesis and Therapy, Volume 4, Issue 6 Author(s): Sanath Devanahally, Sonal Dubey

Читать у издателя →

Похожие статьи